~Torrent Pharma reported strong Q1 FY27 results with revenue rising 55% YoY to ₹4,921 crore, Operating EBITDA up 61% to ₹1,664 crore and PAT at ₹566 crore.
Ahmedabad, Gujarat, July 30 (VNI): Torrent Pharmaceuticals Limited on Thursday announced its financial results for the first quarter of FY27, reporting a strong financial performance with revenue rising 55% year-on-year to ₹4,921 crore.
The company reported Operating EBITDA of ₹1,664 crore, registering a 61% year-on-year growth, while the Operating EBITDA margin stood at 33.8%. The Gross Margin was 76.4%, reflecting continued operational efficiency. Net Profit after Tax (PAT) for the quarter stood at ₹566 crore.
Torrent Pharma said the robust quarterly performance was driven by strong operational execution and continued momentum across its business segments.
Torrent Pharmaceuticals is the flagship company of the Torrent Group, which has group revenues of approximately ₹50,000 crore. The company is ranked fifth in the Indian Pharmaceutical Market and is among the Top 5 in key therapeutic segments, including Cardiovascular (CV), Gastrointestinal (GI), Central Nervous System (CNS), Pain Management, and Dermatology. VNI NEWS, Torrent Pharma Q1 FY27, Torrent Pharmaceuticals Results, Q1 FY27 Revenue, Pharma Earnings, Ahmedabad Business News, Torrent Pharma, Q1 FY27 Results, Pharmaceuticals, Financial Results, Business News, Ahmedabad, Gujarat, EBITDA, Net Profit, VNINews, VNINews.com